ITGI Medical, a company engaged with research, development, manufacturing and marketing of heterologous tissue covered stents, announced that AneuGraft, its second heterologous tissue covered stent, received CE Mark approval.
AneuGraft is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations in tortuous vessels.
“AneuGraft Pericardium Covered Stent is especially suitable for patients with tortuous vessels where other covered stents may not be adequate for use due to limitations resulting from tortuous anatomy,” says Efri Argaman, ITGI Medical CEO.
The CE Mark approval for AneuGraft will enable ITGI Medical to provide a wide range of coronary interventional solutions for all those situations that need to set a barrier between the vessel wall and its lumen, despite the anatomical limitations. The AneuGraft is mounted on a delivery system specially designed to improve the stent navigability in tortuous vessels.
